ReviewNeurologia medico-chirurgica2018

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas.

Hideaki Abe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.